G., & Meister, A
Unlike standard supplements, the liposomal structure protects the ingredient, helping your body utilize it more effectively
These effects could potentially be beneficial in treating various neurological conditions, though clinical evidence remains extremely limited
Technically, yes for a short period
For example, CYP2C9 and CYP2C19 variants (in particular CYP2C9 poor metabolizer genotypes), are associated with phenytoin-induced SJS/TEN even in the absence of HLA-B*1502 [46, 47]
Giulimondi, F., Digiacomo, L., Pozzi, D., Palchetti, S., Vulpis, E., Capriotti, A.L., Chiozzi, R.Z., Lagan, A., Amenitsch, H., Masuelli, L., Peruzzi, G., Mahmoudi, M., Screpanti, I., Zingoni, A